[go: up one dir, main page]

PL1774356T3 - Sposób oznaczania lipoprotein w płynach ustrojowych - Google Patents

Sposób oznaczania lipoprotein w płynach ustrojowych

Info

Publication number
PL1774356T3
PL1774356T3 PL05753614T PL05753614T PL1774356T3 PL 1774356 T3 PL1774356 T3 PL 1774356T3 PL 05753614 T PL05753614 T PL 05753614T PL 05753614 T PL05753614 T PL 05753614T PL 1774356 T3 PL1774356 T3 PL 1774356T3
Authority
PL
Poland
Prior art keywords
lipoproteins
determination
body fluids
fluids
Prior art date
Application number
PL05753614T
Other languages
English (en)
Inventor
Fritz Huber
Werner Kremer
Hans Robert Kalbitzer
Original Assignee
Numares Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Numares Ag filed Critical Numares Ag
Publication of PL1774356T3 publication Critical patent/PL1774356T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/4625—Processing of acquired signals, e.g. elimination of phase errors, baseline fitting, chemometric analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Signal Processing (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL05753614T 2004-06-01 2005-06-01 Sposób oznaczania lipoprotein w płynach ustrojowych PL1774356T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57617304P 2004-06-01 2004-06-01
DE102004026903A DE102004026903B4 (de) 2004-06-01 2004-06-01 Verfahren zur Bestimmung von Lipoproteinen in Körperflüssigkeiten und Messanordnung dafür
PCT/EP2005/005886 WO2005119285A1 (en) 2004-06-01 2005-06-01 Process for the determination of lipoproteins in body fluids
EP05753614.6A EP1774356B1 (en) 2004-06-01 2005-06-01 Process for the determination of lipoproteins in body fluids

Publications (1)

Publication Number Publication Date
PL1774356T3 true PL1774356T3 (pl) 2015-05-29

Family

ID=35454860

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05753614T PL1774356T3 (pl) 2004-06-01 2005-06-01 Sposób oznaczania lipoprotein w płynach ustrojowych

Country Status (8)

Country Link
US (1) US7927878B2 (pl)
EP (1) EP1774356B1 (pl)
AU (1) AU2005250571B2 (pl)
CA (1) CA2568705C (pl)
DE (1) DE102004026903B4 (pl)
ES (1) ES2529040T3 (pl)
PL (1) PL1774356T3 (pl)
WO (1) WO2005119285A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2542107A1 (en) 2003-10-23 2005-05-12 Liposcience, Inc. Methods, systems and computer programs for assessing chd risk using mathematical models that consider in vivo concentration gradients of ldl particle subclasses of discrete size
AU2005230449B2 (en) * 2004-04-01 2010-02-18 Liposcience, Inc. NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples
US20070202008A1 (en) * 2006-02-28 2007-08-30 Schembri Carol T Systems and methods of lipoprotein size fraction assaying
WO2007133593A2 (en) 2006-05-10 2007-11-22 Liposcience, Inc. Methods, systems and computer programs for assessing chd risk using weighted hdl particle number measurements
RU2326369C2 (ru) * 2006-07-03 2008-06-10 Государственное образовательное учреждение высшего профессионального образорвания "Санкт-Петербургский государственный технологический институт (технический университет)" Способ измерения концентрации
DE102009005207A1 (de) 2008-06-17 2010-01-07 Universität Regensburg Verfahren zur Bestimmung von Lipoproteinkomponenten in einem zu analysierenden Lipoproteingemisch
EP2344890B1 (en) * 2008-10-20 2021-08-11 Liposcience, Inc. Lipoprotein insulin resistance indexes and related methods
DE102011005100B4 (de) 2011-03-04 2012-11-22 Siemens Aktiengesellschaft Verfahren zur automatischen Bestimmung von Parametern einer Phasenkontrast-Flussmessung sowie entsprechende Magnetresonanzanlage
US9322833B2 (en) 2011-06-16 2016-04-26 Children's Hospital & Research Center At Oakland Ultra-small ApoB-containing particles and methods of use thereof
US9361429B2 (en) 2012-06-08 2016-06-07 Liposcience, Inc. Multi-parameter diabetes risk evaluations
US9928345B2 (en) 2012-06-08 2018-03-27 Liposciences, Inc. Multiple-marker risk parameters predictive of conversion to diabetes
US9551768B2 (en) 2013-03-15 2017-01-24 East Carolina University NMR method for monitoring changes in the core of lipoprotein particles in metabolism and disease
EP2972325B1 (en) 2013-03-15 2020-09-23 Helena Laboratories Corporation System and method for assessing quantities or sizes of lipoprotein particles from lipoprotein particle compositions
US20150260631A1 (en) * 2014-03-17 2015-09-17 Health Diagnostic Laboratory, Inc. System and method for assessing quanitites or sizes of lipoprotein particles from lipoprotein particle compositions
CN106415276B (zh) * 2013-11-27 2018-10-16 威尔吉利健康研究所 用于表征脂蛋白的方法
DE102016224691A1 (de) * 2016-12-12 2018-06-14 Numares Ag Verfahren zur Analyse eines NMR-Spektrums einer lipoproteinhaltigen Probe
US10775458B2 (en) 2018-03-05 2020-09-15 Texas Tech University System Method and system for non-invasive measurement of metabolic health

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933844A (en) * 1988-09-26 1990-06-12 Otvos James D Measurement of blood lipoprotein constituents by analysis of data acquired from an NMR spectrometer
WO1993003450A1 (en) 1991-07-30 1993-02-18 North Carolina State University Method and apparatus for measuring blood lipoprotein levels by nmr spectroscopy
US6653140B2 (en) 1999-02-26 2003-11-25 Liposcience, Inc. Methods for providing personalized lipoprotein-based risk assessments
WO2000051054A1 (en) 1999-02-26 2000-08-31 Lipomed, Inc. Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood
US7901873B2 (en) * 2001-04-23 2011-03-08 Tcp Innovations Limited Methods for the diagnosis and treatment of bone disorders
WO2003012416A1 (en) 2001-08-01 2003-02-13 Liposcience, Inc. Method of determining presence and concentration of lipoprotein x in blood plasma and serum
CA2542107A1 (en) * 2003-10-23 2005-05-12 Liposcience, Inc. Methods, systems and computer programs for assessing chd risk using mathematical models that consider in vivo concentration gradients of ldl particle subclasses of discrete size

Also Published As

Publication number Publication date
US7927878B2 (en) 2011-04-19
DE102004026903B4 (de) 2006-05-18
CA2568705A1 (en) 2005-12-15
ES2529040T3 (es) 2015-02-16
EP1774356B1 (en) 2014-11-19
AU2005250571A1 (en) 2005-12-15
DE102004026903A1 (de) 2005-12-29
WO2005119285A1 (en) 2005-12-15
EP1774356A1 (en) 2007-04-18
US20080038829A1 (en) 2008-02-14
AU2005250571B2 (en) 2010-08-26
CA2568705C (en) 2015-08-04

Similar Documents

Publication Publication Date Title
GB2413636B (en) Method for determining the properties of formation fluids
IL188078A0 (en) Nano-ionic liquids and methods of use
GB0422447D0 (en) Use of ionic liquids
IL192166A0 (en) Novel quantitative and qulitative analysis apparatus for measuring the body fluid
IL184435A0 (en) Apparatus for use in the construction of buildings
EP1946830A4 (en) MICROREACTOR AND METHOD OF LIQUIDATION USING THEREOF
IL186447A0 (en) Methods for the treatment of substance abuse and dependence
EP1818003A4 (en) DEVICE INTRODUCED IN A SUBJECT
SI2100618T1 (sl) Antagonisti receptorja za zdravljenje metastaznega kostnega raka
ZA200704876B (en) Dielectric fluids and processes for making same
PL1774356T3 (pl) Sposób oznaczania lipoprotein w płynach ustrojowych
GB2421958B (en) Dielectric fluids and processes for making same
GB0515815D0 (en) Well treatment fluid
ZA200706113B (en) Method for the treatment of copper-bearing materials
IL162761A0 (en) Devices for continuous measurement of glucose in body fluids
IL178816A0 (en) The treatment of childhood asthma
ZA200709443B (en) Methods for the treatment of substance abuse and dependence
EP2017677A4 (en) LIQUID REVELATOR AND PROCESS FOR PRODUCTION THEREOF
EP1836470A4 (en) APPARATUS FOR ANALYZING LIQUIDS
EP1955654A4 (en) COLLECTION OF BIOLOGICAL LIQUID AND METHOD
IL180199A0 (en) Process for improvement of virus- safe biological fluids
GB2417232B (en) Container for fluids
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
IL181785A0 (en) Use of epothilones in the treatment of bone metastasis
GB0505664D0 (en) Low volume assay apparatus and method